Login / Signup

Recurrent repeat expansions in human cancer genomes.

Graham S ErwinGamze GürsoyRashid Al-AbriAshwini SuriyaprakashEgor DolzhenkoKevin ZhuChristian R HoernerShannon M WhiteLucia RamirezAnanya VadlakondaAlekhya VadlakondaKonor von KrautJulia ParkCharlotte M BrannonDaniel A SumanoRaushun A KirtikarAlicia A ErwinThomas J MetznerRyan K C YuenAlice C FanJohn T LeppertMichael A EberleMark B GersteinMichael Paul Snyder
Published in: Nature (2022)
Expansion of a single repetitive DNA sequence, termed a tandem repeat (TR), is known to cause more than 50 diseases 1,2 . However, repeat expansions are often not explored beyond neurological and neurodegenerative disorders. In some cancers, mutations accumulate in short tracts of TRs, a phenomenon termed microsatellite instability; however, larger repeat expansions have not been systematically analysed in cancer 3-8 . Here we identified TR expansions in 2,622 cancer genomes spanning 29 cancer types. In seven cancer types, we found 160 recurrent repeat expansions (rREs), most of which (155/160) were subtype specific. We found that rREs were non-uniformly distributed in the genome with enrichment near candidate cis-regulatory elements, suggesting a potential role in gene regulation. One rRE, a GAAA-repeat expansion, located near a regulatory element in the first intron of UGT2B7 was detected in 34% of renal cell carcinoma samples and was validated by long-read DNA sequencing. Moreover, in preliminary experiments, treating cells that harbour this rRE with a GAAA-targeting molecule led to a dose-dependent decrease in cell proliferation. Overall, our results suggest that rREs may be an important but unexplored source of genetic variation in human cancer, and we provide a comprehensive catalogue for further study.
Keyphrases